SOURCE: Medpace


January 14, 2010 07:00 ET

Medpace Sets Groundbreaking for Global Headquarters in Madisonville

Al. Neyer, Inc. to Start Design-Build Construction on First Building January 2010

CINCINNATI, OH--(Marketwire - January 14, 2010) -

                            January 14, 2010
                               10:00 a.m.
          Madison Road & Red Bank Expressway, southeast corner

Medpace, Inc., a global leader in clinical research for the pharmaceutical and biotechnology industries, has announced it is beginning construction on its new corporate headquarters in the City of Cincinnati's Madisonville neighborhood.

City of Cincinnati Mayor Mark Mallory and City Manager Milton Dohoney, Jr. will join State of Ohio Development Director Lisa Patt-McDaniel in the January 14, 10 a.m. groundbreaking ceremony for Medpace. Laura Brunner, Executive Vice President, Al. Neyer, Inc., August Troendle, Medpace President and CEO, and Robert Igoe of the Madisonville Community Council are also expected to provide remarks at the start-of-construction event at the site.

Medpace said it has hired Al. Neyer, Inc. to design and build a 132,000-square foot facility as part of a new 29-acre development at Madison Road and Red Bank Expressway. A Medpace related organization purchased the site and Medpace was granted Ohio Job Creation Tax Credits and a City of Cincinnati Job Creation Tax Credit in 2008.

The new facility is the first of what is envisioned as at least two separate office buildings for Medpace. The company is growing rapidly and will bring its current 600 employees from Norwood to the new facility, as well as add an estimated 760 new jobs by the year 2014.

"We have received tremendous support from the State of Ohio, City of Cincinnati, and the Madisonville community to accommodate our expanding needs at the Red Bank site," according to August Troendle, President and CEO of Medpace. "Building a state-of-the-art facility will support long-term Medpace growth and define our corporate presence in Cincinnati. It has been rewarding to reclaim a former industrial site for the benefit of the surrounding community."

The City of Cincinnati recently was awarded $3 million in state grant money to clean up the property. The site had been formerly occupied by NuTone, a manufacturer of door chimes, fans and other products.

"From site preparation and remediation to business development support, collaboration between Cincinnati, the State of Ohio, and Medpace is creating jobs for Ohioans and growth for our economy," said Lisa Patt-McDaniel, Director of the Ohio Department of Development. "Regional strengths in the pharmaceutical and biomedical industries help to make a strong case for investment in our state, and we welcome Medpace's decision to grow in Ohio."

"This is the type of job creation deal that our GO Cincinnati strategy is designed to produce," Mayor Mark Mallory said. "By focusing resources in strategic areas, we can attract companies to Cincinnati that will bring skilled, high-paying jobs in the growing industries like life sciences."

Medpace chose Al. Neyer based on the strength of the site plan and building design, as well as its experience building for health-care clients, including Cincinnati Children's Hospital Medical Center, Dayton VA Medical Center and Mayfield Clinic.

"We're delighted to work with Medpace, designing a global headquarters to LEED-Certification specifications," said David Neyer, President, CEO, Al. Neyer, Inc "This project represents new vitality in a green environment that defines our collective interpretation of a healthy economic future."


Medpace is a leading global full-service clinical research organization providing Phase I-IV core development services for drug, biologic, and device programs. With medical and regulatory expertise in multiple therapeutic specialties, Medpace has assembled the industry's most experienced and therapeutically focused teams to execute at every level of the company's operations, providing complete and seamless drug development services. In June 2009 Medpace was rated as the best CRO by U.S. Investigators in the 2009 CenterWatch Site Survey.

Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development -- from program planning and execution to product approval.

With more than 1,000 employees and clinical trial experience in over 40 countries, Medpace has the global reach and capability to conduct studies and navigate regulatory requirements worldwide. In addition to Phase II-IV development services, Medpace provides Phase I / IIA clinical services from Medpace Clinical Pharmacology, central laboratory and therapeutically specialized testing from Medpace Reference Laboratories, complete bioanalytical services in all stages of drug development from Medpace Bioanalytical Laboratories, and central image management and reading from Imagepace.


Al. Neyer, Inc. is a 115-year-old commercial real estate development, investment and design-build company, responsible for millions of square feet of office, medical office, industrial and residential mixed-use space that contributes to the economic vitality of cities in which we build.

Al. Neyer recently completed construction of a 120,000-square-foot medical office and treatment facility at 3430 Burnet Avenue for Cincinnati Children's Hospital Medical Center in Avondale that includes a 1,450-vehicle parking garage, and 3-story LEED-CS Gold office and neighborhood retail building. The company is responsible for the 2009 redevelopment of the Offices at 444 West Third Street, headquarters for dunnhumbyUSA. It has initiated redevelopment of the Vernon Manor, a former hotel, as office space for Cincinnati Children's.

Al. Neyer leads in green building design and construction practices. Seven of our staff holds LEED Accredited Professional credentials and the company has been involved in three LEED regisprojects and significant redevelopment projects involving brownfields. Al. Neyer consistently ranks among Greater Cincinnati's largest privately held companies.

Contact Information